The Italian-Austrian team of PreCanMed convene today in Trieste to mark the start of the cross-border project ‘PreCanMed – Creating a platform for precision anticancer medicine’.

The meeting is hosted by Area Science Park, the science & technology park in Trieste where the lead partner institution, the Consorzio Interuniversitario per le Biotecnologie – Laboratorio Nazionale CIB (LNCIB), is embedded. The meeting will set the details of partners’ first actions.